- Published on
Infectious Disease and Microbiology - Mastoiditis
Mastoiditis is an infection and inflammation of the mastoid air cells of the temporal bone, typically classified as acute or chronic based on duration. Acute mastoiditis usually follows untreated or inadequately treated middle ear infection, whereas chronic mastoiditis is characterized by persistent ear discharge lasting more than three weeks, often associated with a perforated tympanic membrane.
The incidence of mastoiditis has significantly declined in the antibiotic era due to prompt treatment of otitis media. However, a recent shift toward conservative management of ear infections has led to a slight increase in cases in some regions. It remains a relatively rare condition, with incidence rates ranging from approximately 1.2 to 3.8 cases per 100,000 patient-years. Risk factors include inadequate treatment of otitis media, lack of vaccination against Streptococcus pneumoniae and Haemophilus influenzae, and the presence of cochlear implants.
The disease typically develops as an extension of infection from the middle ear into the mastoid air cells. In acute mastoiditis, the most common causative organisms mirror those of acute otitis media, including Streptococcus pneumoniae, Haemophilus influenzae, Streptococcus pyogenes, and Pseudomonas aeruginosa. Chronic mastoiditis is often polymicrobial, involving organisms such as Pseudomonas aeruginosa, Staphylococcus aureus, gram-negative bacilli, anaerobes, and rarely fungi or mycobacteria.
Clinically, patients often present with symptoms of acute otitis media, including fever, ear pain, and hearing impairment. Physical examination reveals erythema of the tympanic membrane, ear discharge (otorrhea), and characteristic postauricular findings such as swelling, tenderness, and redness over the mastoid region. A key sign is displacement of the pinna outward and downward. In chronic cases, symptoms may be more subtle, including persistent ear discharge and hearing loss.
Diagnosis is supported by laboratory findings such as elevated white blood cell count and inflammatory markers (CRP and ESR). Imaging plays a crucial role, with radiographs showing destruction of mastoid air cell septa and fluid accumulation, while CT or MRI provides detailed assessment of disease extent and complications. Microbiological diagnosis is achieved through culture of ear discharge or middle ear fluid obtained via tympanocentesis.
Management requires prompt and aggressive treatment due to the risk of serious complications. Intravenous antibiotics are the mainstay of therapy, typically using broad-spectrum agents such as third- or fourth-generation cephalosporins, piperacillin-tazobactam, or combinations targeting resistant organisms. Treatment duration is usually 3–4 weeks, with transition to oral therapy after clinical improvement. Chronic mastoiditis may also require local antibiotic therapy and meticulous ear care.
Surgical intervention is indicated in cases of treatment failure, complications, or evidence of bone destruction. Procedures such as mastoidectomy are performed to remove infected tissue and prevent further spread. Less invasive approaches, including drainage and ventilation tube placement, may be considered in selected cases without intracranial involvement.
The prognosis is generally very good when mastoiditis is diagnosed early and treated appropriately. However, delayed or inadequate treatment can lead to serious complications, including subperiosteal abscess, facial nerve paralysis, intracranial infections such as meningitis or brain abscess, and permanent hearing loss.
- Published on
1. Infectious Disease and Microbiology - Malaria
Malaria is a vector-borne parasitic disease transmitted by the bite of an infected female Anopheles mosquito. It is caused by protozoa of the genus Plasmodium and remains one of the most significant global infectious diseases, particularly affecting tropical and subtropical regions. The infection begins when sporozoites are introduced into the bloodstream, subsequently invading liver cells and later red blood cells, leading to systemic illness.
Malaria has a massive global burden, with hundreds of millions of cases annually and millions of deaths, most of which occur in children. It affects over 40% of the world’s population across more than 100 countries. Different species have distinct geographic distributions: Plasmodium falciparum predominates in Africa and is responsible for the most severe disease, while P. vivax, P. ovale, and P. malariae are distributed across other regions. Risk factors include travel to endemic areas, lack of immunity, and, rarely, transmission through blood transfusion or from mother to fetus. Certain genetic traits, such as sickle cell trait, offer partial protection against severe disease.
The pathophysiology involves a complex life cycle between the mosquito and human host. After liver-stage development, parasites invade red blood cells, multiply, and cause their destruction. This leads to hemolysis, release of inflammatory cytokines, and the characteristic febrile illness. P. falciparum is particularly dangerous due to its ability to cause cytoadherence, leading to sequestration of infected red blood cells in small blood vessels, resulting in impaired blood flow and organ dysfunction.
Clinically, malaria presents with nonspecific symptoms such as fever, malaise, headache, and myalgias. A hallmark feature is the malarial paroxysm, consisting of a cold stage with chills, a hot stage with high fever (often exceeding 40°C), and a sweating stage with resolution of fever and profound fatigue. Splenomegaly and tachycardia are common findings. Although fever patterns may be cyclic (tertian or quartan), this periodicity is not always reliable for diagnosis.
Diagnosis is primarily established by microscopic examination of thick and thin blood smears, which allows detection and identification of the parasite species. Rapid diagnostic tests detecting specific antigens are also widely used, especially in resource-limited settings. Laboratory findings often include anemia, thrombocytopenia, and markers of hemolysis. Molecular methods such as PCR can provide confirmation but are not routinely available.
Treatment depends on the species, severity, and drug resistance patterns. Uncomplicated malaria caused by chloroquine-sensitive strains can be treated with chloroquine, while resistant infections require agents such as atovaquone-proguanil, artemisinin-based combinations, or quinine-based regimens. Severe malaria, particularly due to P. falciparum, is a medical emergency requiring intravenous therapy such as artesunate or quinidine, along with intensive supportive care. Monitoring for complications such as hypoglycemia and renal failure is essential.
Preventive strategies focus on reducing mosquito exposure and chemoprophylaxis. Measures include insecticide-treated bed nets, protective clothing, and repellents such as DEET. Travelers to endemic regions may require prophylactic medications depending on resistance patterns. Individuals returning to endemic areas after prolonged absence are at increased risk due to loss of immunity.
The prognosis of malaria depends on early diagnosis and appropriate treatment. Uncomplicated malaria generally responds well to therapy, while untreated P. falciparum infection can lead to severe complications such as cerebral malaria, renal failure, metabolic acidosis, and death. Prompt recognition and management are critical to reducing morbidity and mortality.
Malaria is a vector-borne parasitic disease transmitted by the bite of an infected female Anopheles mosquito. It is caused by protozoa of the genus Plasmodium and remains one of the most significant global infectious diseases, particularly affecting tropical and subtropical regions. The infection begins when sporozoites are introduced into the bloodstream, subsequently invading liver cells and later red blood cells, leading to systemic illness.
Malaria has a massive global burden, with hundreds of millions of cases annually and millions of deaths, most of which occur in children. It affects over 40% of the world’s population across more than 100 countries. Different species have distinct geographic distributions: Plasmodium falciparum predominates in Africa and is responsible for the most severe disease, while P. vivax, P. ovale, and P. malariae are distributed across other regions. Risk factors include travel to endemic areas, lack of immunity, and, rarely, transmission through blood transfusion or from mother to fetus. Certain genetic traits, such as sickle cell trait, offer partial protection against severe disease.
The pathophysiology involves a complex life cycle between the mosquito and human host. After liver-stage development, parasites invade red blood cells, multiply, and cause their destruction. This leads to hemolysis, release of inflammatory cytokines, and the characteristic febrile illness. P. falciparum is particularly dangerous due to its ability to cause cytoadherence, leading to sequestration of infected red blood cells in small blood vessels, resulting in impaired blood flow and organ dysfunction.
Clinically, malaria presents with nonspecific symptoms such as fever, malaise, headache, and myalgias. A hallmark feature is the malarial paroxysm, consisting of a cold stage with chills, a hot stage with high fever (often exceeding 40°C), and a sweating stage with resolution of fever and profound fatigue. Splenomegaly and tachycardia are common findings. Although fever patterns may be cyclic (tertian or quartan), this periodicity is not always reliable for diagnosis.
Diagnosis is primarily established by microscopic examination of thick and thin blood smears, which allows detection and identification of the parasite species. Rapid diagnostic tests detecting specific antigens are also widely used, especially in resource-limited settings. Laboratory findings often include anemia, thrombocytopenia, and markers of hemolysis. Molecular methods such as PCR can provide confirmation but are not routinely available.
Treatment depends on the species, severity, and drug resistance patterns. Uncomplicated malaria caused by chloroquine-sensitive strains can be treated with chloroquine, while resistant infections require agents such as atovaquone-proguanil, artemisinin-based combinations, or quinine-based regimens. Severe malaria, particularly due to P. falciparum, is a medical emergency requiring intravenous therapy such as artesunate or quinidine, along with intensive supportive care. Monitoring for complications such as hypoglycemia and renal failure is essential.
Preventive strategies focus on reducing mosquito exposure and chemoprophylaxis. Measures include insecticide-treated bed nets, protective clothing, and repellents such as DEET. Travelers to endemic regions may require prophylactic medications depending on resistance patterns. Individuals returning to endemic areas after prolonged absence are at increased risk due to loss of immunity.
The prognosis of malaria depends on early diagnosis and appropriate treatment. Uncomplicated malaria generally responds well to therapy, while untreated P. falciparum infection can lead to severe complications such as cerebral malaria, renal failure, metabolic acidosis, and death. Prompt recognition and management are critical to reducing morbidity and mortality.
- Published on
Infectious Disease and Microbiology - Lymphangitis
Lymphangitis is an inflammatory condition of the lymphatic channels that typically occurs as a result of infection at a distal site. The condition arises when pathogens enter the lymphatic vessels through a break in the skin, such as a cut, abrasion, insect bite, or underlying skin infection, and spread proximally toward regional lymph nodes. It is commonly associated with visible red streaks extending from the site of infection.
Although specific epidemiologic data are limited, several risk factors predispose individuals to lymphangitis. These include lymphedema, trauma, insect bites or stings, and preexisting skin conditions such as fungal infections like tinea pedis. Children with underlying conditions such as diabetes, immunodeficiency, or those receiving chronic steroid therapy are at increased risk of developing more severe or rapidly progressive disease.
The pathophysiology involves direct invasion of lymphatic vessels by microorganisms. Once pathogens enter, they trigger local inflammation, leading to characteristic erythematous streaking along lymphatic channels. The infection may then spread toward regional lymph nodes, causing lymphadenopathy and systemic symptoms if dissemination occurs.
The most common causative organisms in immunocompetent individuals are group A beta-hemolytic streptococci. Staphylococcus aureus is another frequent pathogen, while other organisms such as Pseudomonas species, Pasteurella multocida (associated with animal bites), and Aeromonas hydrophila (associated with freshwater exposure) may also be involved. In immunocompromised hosts, gram-negative bacteria and fungi may play a role. Nodular lymphangitis, characterized by a sporotrichoid pattern, is often associated with organisms such as Sporothrix schenckii, Mycobacterium marinum, and Nocardia brasiliensis.
Patients typically present with a history of recent skin trauma or infection. Symptoms often include fever, chills, malaise, and localized pain. On physical examination, erythematous, warm, and tender linear streaks are seen extending from the primary infection site toward regional lymph nodes. The primary lesion may be an abscess, cellulitis, or infected wound. Regional lymph nodes are often enlarged and tender, and systemic signs such as tachycardia may be present in more severe cases.
Diagnosis is primarily clinical but may be supported by laboratory findings. A complete blood count often reveals leukocytosis, and blood cultures may be obtained, although they are frequently negative. Culture and Gram staining of material from the primary infection site can help identify the causative organism and guide antimicrobial therapy. In cases of nodular lymphangitis, cultures for fungi and mycobacteria or histopathological examination may be necessary. Imaging is generally not required in routine cases.
Management involves prompt initiation of appropriate antimicrobial therapy targeting the most likely pathogens, particularly streptococci and Staphylococcus aureus. Outpatient treatment may include penicillinase-resistant penicillins or first-generation cephalosporins, while more severe cases require intravenous antibiotics such as second- or third-generation cephalosporins. In regions with high prevalence of methicillin-resistant Staphylococcus aureus, agents such as clindamycin or trimethoprim-sulfamethoxazole may be considered. Supportive measures, including analgesics, anti-inflammatory medications, and warm compresses, can help alleviate symptoms. Abscesses, if present, may require incision and drainage.
Close monitoring is essential, especially in children and patients with systemic symptoms. Those who do not respond to oral therapy within 48 hours or who exhibit signs of systemic illness should receive intravenous treatment. Preventive measures include proper wound care, management of underlying skin conditions, and protection against skin trauma.
The prognosis for uncomplicated lymphangitis is generally excellent, with most patients responding well to antimicrobial therapy. However, if left untreated, the infection can progress rapidly, leading to complications such as cellulitis, bacteremia, sepsis, and, in severe cases, tissue necrosis or death. Prompt recognition and treatment are therefore critical.
Lymphangitis is an inflammatory condition of the lymphatic channels that typically occurs as a result of infection at a distal site. The condition arises when pathogens enter the lymphatic vessels through a break in the skin, such as a cut, abrasion, insect bite, or underlying skin infection, and spread proximally toward regional lymph nodes. It is commonly associated with visible red streaks extending from the site of infection.
Although specific epidemiologic data are limited, several risk factors predispose individuals to lymphangitis. These include lymphedema, trauma, insect bites or stings, and preexisting skin conditions such as fungal infections like tinea pedis. Children with underlying conditions such as diabetes, immunodeficiency, or those receiving chronic steroid therapy are at increased risk of developing more severe or rapidly progressive disease.
The pathophysiology involves direct invasion of lymphatic vessels by microorganisms. Once pathogens enter, they trigger local inflammation, leading to characteristic erythematous streaking along lymphatic channels. The infection may then spread toward regional lymph nodes, causing lymphadenopathy and systemic symptoms if dissemination occurs.
The most common causative organisms in immunocompetent individuals are group A beta-hemolytic streptococci. Staphylococcus aureus is another frequent pathogen, while other organisms such as Pseudomonas species, Pasteurella multocida (associated with animal bites), and Aeromonas hydrophila (associated with freshwater exposure) may also be involved. In immunocompromised hosts, gram-negative bacteria and fungi may play a role. Nodular lymphangitis, characterized by a sporotrichoid pattern, is often associated with organisms such as Sporothrix schenckii, Mycobacterium marinum, and Nocardia brasiliensis.
Patients typically present with a history of recent skin trauma or infection. Symptoms often include fever, chills, malaise, and localized pain. On physical examination, erythematous, warm, and tender linear streaks are seen extending from the primary infection site toward regional lymph nodes. The primary lesion may be an abscess, cellulitis, or infected wound. Regional lymph nodes are often enlarged and tender, and systemic signs such as tachycardia may be present in more severe cases.
Diagnosis is primarily clinical but may be supported by laboratory findings. A complete blood count often reveals leukocytosis, and blood cultures may be obtained, although they are frequently negative. Culture and Gram staining of material from the primary infection site can help identify the causative organism and guide antimicrobial therapy. In cases of nodular lymphangitis, cultures for fungi and mycobacteria or histopathological examination may be necessary. Imaging is generally not required in routine cases.
Management involves prompt initiation of appropriate antimicrobial therapy targeting the most likely pathogens, particularly streptococci and Staphylococcus aureus. Outpatient treatment may include penicillinase-resistant penicillins or first-generation cephalosporins, while more severe cases require intravenous antibiotics such as second- or third-generation cephalosporins. In regions with high prevalence of methicillin-resistant Staphylococcus aureus, agents such as clindamycin or trimethoprim-sulfamethoxazole may be considered. Supportive measures, including analgesics, anti-inflammatory medications, and warm compresses, can help alleviate symptoms. Abscesses, if present, may require incision and drainage.
Close monitoring is essential, especially in children and patients with systemic symptoms. Those who do not respond to oral therapy within 48 hours or who exhibit signs of systemic illness should receive intravenous treatment. Preventive measures include proper wound care, management of underlying skin conditions, and protection against skin trauma.
The prognosis for uncomplicated lymphangitis is generally excellent, with most patients responding well to antimicrobial therapy. However, if left untreated, the infection can progress rapidly, leading to complications such as cellulitis, bacteremia, sepsis, and, in severe cases, tissue necrosis or death. Prompt recognition and treatment are therefore critical.
- Published on
Infectious Disease and Microbiology - Lyme disease
Lyme disease is a multisystem, tick-borne infection caused by spirochetes of the genus Borrelia. It typically begins at the site of a bite from an infected Ixodes tick, followed by local spread in the skin and eventual dissemination through the bloodstream or lymphatic system to multiple organs, including joints, the nervous system, heart, and skin. The disease progresses through three stages: early localized, early disseminated, and late disease. It was first recognized in 1977 after a cluster of arthritis cases in children near Lyme, Connecticut.
Epidemiologically, Lyme disease is the most common tick-borne infection in North America and Europe. The highest incidence occurs in specific endemic regions, particularly along the northeastern United States and parts of the Midwest. Risk is strongly associated with outdoor activities such as hiking, camping, or occupational exposure in wooded or grassy areas where ticks are prevalent. Transmission usually requires the tick to remain attached for more than 36 hours, although many patients do not recall a tick bite. Preventive strategies include wearing protective clothing, using insect repellents such as DEET, and prompt tick removal. In certain high-risk exposures, a single prophylactic dose of doxycycline may be considered.
The causative organism in the United States is Borrelia burgdorferi, while Borrelia afzelii and Borrelia garinii are more common in Europe and Asia. After entering the skin, the organism spreads locally and may later disseminate systemically. The clinical manifestations depend on the stage of the disease and the host immune response.
In early localized disease, the hallmark finding is erythema migrans, an expanding skin lesion that appears days to weeks after the tick bite. It often presents as a red macule or papule that enlarges into a characteristic annular rash with central clearing. This stage may also be accompanied by mild systemic symptoms such as fever, fatigue, and headache.
Early disseminated disease occurs weeks to months later and involves multiple organ systems. Patients may develop multiple secondary skin lesions, migratory musculoskeletal pain, and neurologic manifestations such as meningitis or facial nerve palsy. Cardiac involvement may occur, most commonly presenting as atrioventricular conduction abnormalities. Ocular symptoms and mild hepatitis may also be seen.
Late disease develops months to years after untreated infection and is characterized primarily by chronic arthritis, especially affecting large joints such as the knee. Neurologic complications may include encephalopathy or polyneuropathy. Certain dermatologic manifestations, such as acrodermatitis chronica atrophicans, are more commonly observed in Europe. Some patients may experience persistent symptoms such as fatigue or cognitive difficulties after treatment, a condition referred to as post–Lyme disease syndrome.
Diagnosis is based on clinical findings, history of exposure, and laboratory testing. A two-step serologic approach is recommended, beginning with an enzyme immunoassay or immunofluorescence assay, followed by confirmatory Western blot testing if positive or equivocal. Laboratory testing has limitations, particularly in early disease when antibodies may not yet be detectable. PCR testing may be useful in certain cases, such as analysis of synovial or cerebrospinal fluid.
Treatment depends on the stage and manifestations of the disease. Early disease is typically treated with oral antibiotics such as doxycycline, amoxicillin, or cefuroxime. More severe or disseminated disease, particularly with neurologic or cardiac involvement, may require intravenous therapy with ceftriaxone. The duration of therapy varies from 2 to 4 weeks depending on the clinical scenario. In cases of persistent arthritis or complications, additional supportive or symptomatic treatments may be required.
The prognosis is generally excellent when Lyme disease is recognized and treated early. However, delayed diagnosis may result in chronic complications such as persistent arthritis or neurologic impairment. Careful monitoring and appropriate management of complications are essential to ensure optimal outcomes.
Lyme disease is a multisystem, tick-borne infection caused by spirochetes of the genus Borrelia. It typically begins at the site of a bite from an infected Ixodes tick, followed by local spread in the skin and eventual dissemination through the bloodstream or lymphatic system to multiple organs, including joints, the nervous system, heart, and skin. The disease progresses through three stages: early localized, early disseminated, and late disease. It was first recognized in 1977 after a cluster of arthritis cases in children near Lyme, Connecticut.
Epidemiologically, Lyme disease is the most common tick-borne infection in North America and Europe. The highest incidence occurs in specific endemic regions, particularly along the northeastern United States and parts of the Midwest. Risk is strongly associated with outdoor activities such as hiking, camping, or occupational exposure in wooded or grassy areas where ticks are prevalent. Transmission usually requires the tick to remain attached for more than 36 hours, although many patients do not recall a tick bite. Preventive strategies include wearing protective clothing, using insect repellents such as DEET, and prompt tick removal. In certain high-risk exposures, a single prophylactic dose of doxycycline may be considered.
The causative organism in the United States is Borrelia burgdorferi, while Borrelia afzelii and Borrelia garinii are more common in Europe and Asia. After entering the skin, the organism spreads locally and may later disseminate systemically. The clinical manifestations depend on the stage of the disease and the host immune response.
In early localized disease, the hallmark finding is erythema migrans, an expanding skin lesion that appears days to weeks after the tick bite. It often presents as a red macule or papule that enlarges into a characteristic annular rash with central clearing. This stage may also be accompanied by mild systemic symptoms such as fever, fatigue, and headache.
Early disseminated disease occurs weeks to months later and involves multiple organ systems. Patients may develop multiple secondary skin lesions, migratory musculoskeletal pain, and neurologic manifestations such as meningitis or facial nerve palsy. Cardiac involvement may occur, most commonly presenting as atrioventricular conduction abnormalities. Ocular symptoms and mild hepatitis may also be seen.
Late disease develops months to years after untreated infection and is characterized primarily by chronic arthritis, especially affecting large joints such as the knee. Neurologic complications may include encephalopathy or polyneuropathy. Certain dermatologic manifestations, such as acrodermatitis chronica atrophicans, are more commonly observed in Europe. Some patients may experience persistent symptoms such as fatigue or cognitive difficulties after treatment, a condition referred to as post–Lyme disease syndrome.
Diagnosis is based on clinical findings, history of exposure, and laboratory testing. A two-step serologic approach is recommended, beginning with an enzyme immunoassay or immunofluorescence assay, followed by confirmatory Western blot testing if positive or equivocal. Laboratory testing has limitations, particularly in early disease when antibodies may not yet be detectable. PCR testing may be useful in certain cases, such as analysis of synovial or cerebrospinal fluid.
Treatment depends on the stage and manifestations of the disease. Early disease is typically treated with oral antibiotics such as doxycycline, amoxicillin, or cefuroxime. More severe or disseminated disease, particularly with neurologic or cardiac involvement, may require intravenous therapy with ceftriaxone. The duration of therapy varies from 2 to 4 weeks depending on the clinical scenario. In cases of persistent arthritis or complications, additional supportive or symptomatic treatments may be required.
The prognosis is generally excellent when Lyme disease is recognized and treated early. However, delayed diagnosis may result in chronic complications such as persistent arthritis or neurologic impairment. Careful monitoring and appropriate management of complications are essential to ensure optimal outcomes.
- Published on
Infectious Disease and Microbiology - Lung abscess
A lung abscess is a localized collection of pus within the lung parenchyma, resulting in a cavity formed by necrosis of lung tissue due to microbial infection. It may present as a single large cavity or as multiple smaller abscesses, the latter often referred to as necrotizing pneumonia. Lung abscesses can be classified as primary, occurring in otherwise healthy individuals, or secondary, associated with underlying conditions such as malignancy, bronchiectasis, or immunosuppression. Although more common in the pre-antibiotic era, lung abscesses are now relatively uncommon but remain clinically significant due to potential complications.
The most important risk factor is aspiration of oropharyngeal contents, particularly in individuals with impaired consciousness, dysphagia, or poor dental hygiene. Conditions such as alcoholism, general anesthesia, seizures, and gastroesophageal reflux disease increase the risk of aspiration. Periodontal disease plays a major role by providing a source of anaerobic bacteria. Other risk factors include airway obstruction, immunocompromised states such as HIV or diabetes, and hematogenous spread from infections like right-sided endocarditis.
Pathophysiologically, microorganisms—most commonly anaerobic bacteria—enter the lung through aspiration and proliferate in areas with poor clearance. This leads to tissue necrosis and cavity formation. Less commonly, abscesses arise from septic emboli traveling through the bloodstream. The most frequent causative organisms include anaerobes such as Peptostreptococcus, Fusobacterium, Prevotella, and Bacteroides species, often in combination with aerobic bacteria. Aerobic pathogens include Staphylococcus aureus, Klebsiella pneumoniae, and Pseudomonas aeruginosa, with resistant organisms such as MRSA being increasingly recognized.
Clinically, patients typically present with cough producing foul-smelling, purulent sputum, fever, and pleuritic chest pain. In chronic cases, symptoms may persist for weeks and include weight loss, fatigue, night sweats, and malaise. Physical examination may reveal tachycardia, tachypnea, and abnormal lung findings such as crackles, decreased breath sounds, or signs of consolidation. Digital clubbing may develop in longstanding disease.
Diagnosis involves laboratory and imaging studies. Blood tests often show leukocytosis, while sputum cultures may be inconclusive, especially for anaerobic infections. Chest imaging is essential, with radiographs typically showing a cavity with an air–fluid level. CT scanning provides better anatomical detail and helps identify underlying causes such as obstruction or malignancy. Additional procedures such as bronchoscopy or needle aspiration may be required in atypical or nonresponsive cases.
Treatment consists primarily of prolonged antibiotic therapy targeting both anaerobic and aerobic organisms. First-line regimens include clindamycin or beta-lactam/beta-lactamase inhibitor combinations such as ampicillin-sulbactam, followed by oral therapy once clinical improvement occurs. The duration of therapy may extend from several weeks to months, depending on radiologic resolution. Supportive measures such as postural drainage and pulmonary physiotherapy are important adjuncts. In cases unresponsive to medical therapy, percutaneous or surgical drainage may be necessary.
The prognosis is generally good with appropriate treatment, although mortality ranges from 5% to 15%. Poor prognostic factors include large cavity size, delayed diagnosis, underlying comorbidities, and infection with resistant organisms. Complications may include empyema, massive hemoptysis, pneumothorax, and dissemination leading to conditions such as brain abscess. Careful follow-up with serial imaging is required to ensure resolution of the infection.
A lung abscess is a localized collection of pus within the lung parenchyma, resulting in a cavity formed by necrosis of lung tissue due to microbial infection. It may present as a single large cavity or as multiple smaller abscesses, the latter often referred to as necrotizing pneumonia. Lung abscesses can be classified as primary, occurring in otherwise healthy individuals, or secondary, associated with underlying conditions such as malignancy, bronchiectasis, or immunosuppression. Although more common in the pre-antibiotic era, lung abscesses are now relatively uncommon but remain clinically significant due to potential complications.
The most important risk factor is aspiration of oropharyngeal contents, particularly in individuals with impaired consciousness, dysphagia, or poor dental hygiene. Conditions such as alcoholism, general anesthesia, seizures, and gastroesophageal reflux disease increase the risk of aspiration. Periodontal disease plays a major role by providing a source of anaerobic bacteria. Other risk factors include airway obstruction, immunocompromised states such as HIV or diabetes, and hematogenous spread from infections like right-sided endocarditis.
Pathophysiologically, microorganisms—most commonly anaerobic bacteria—enter the lung through aspiration and proliferate in areas with poor clearance. This leads to tissue necrosis and cavity formation. Less commonly, abscesses arise from septic emboli traveling through the bloodstream. The most frequent causative organisms include anaerobes such as Peptostreptococcus, Fusobacterium, Prevotella, and Bacteroides species, often in combination with aerobic bacteria. Aerobic pathogens include Staphylococcus aureus, Klebsiella pneumoniae, and Pseudomonas aeruginosa, with resistant organisms such as MRSA being increasingly recognized.
Clinically, patients typically present with cough producing foul-smelling, purulent sputum, fever, and pleuritic chest pain. In chronic cases, symptoms may persist for weeks and include weight loss, fatigue, night sweats, and malaise. Physical examination may reveal tachycardia, tachypnea, and abnormal lung findings such as crackles, decreased breath sounds, or signs of consolidation. Digital clubbing may develop in longstanding disease.
Diagnosis involves laboratory and imaging studies. Blood tests often show leukocytosis, while sputum cultures may be inconclusive, especially for anaerobic infections. Chest imaging is essential, with radiographs typically showing a cavity with an air–fluid level. CT scanning provides better anatomical detail and helps identify underlying causes such as obstruction or malignancy. Additional procedures such as bronchoscopy or needle aspiration may be required in atypical or nonresponsive cases.
Treatment consists primarily of prolonged antibiotic therapy targeting both anaerobic and aerobic organisms. First-line regimens include clindamycin or beta-lactam/beta-lactamase inhibitor combinations such as ampicillin-sulbactam, followed by oral therapy once clinical improvement occurs. The duration of therapy may extend from several weeks to months, depending on radiologic resolution. Supportive measures such as postural drainage and pulmonary physiotherapy are important adjuncts. In cases unresponsive to medical therapy, percutaneous or surgical drainage may be necessary.
The prognosis is generally good with appropriate treatment, although mortality ranges from 5% to 15%. Poor prognostic factors include large cavity size, delayed diagnosis, underlying comorbidities, and infection with resistant organisms. Complications may include empyema, massive hemoptysis, pneumothorax, and dissemination leading to conditions such as brain abscess. Careful follow-up with serial imaging is required to ensure resolution of the infection.
- Published on
Infectious Disease and Microbiology - Listeriosis
Listeriosis is an infection caused by the gram-positive bacterium Listeria monocytogenes, which is commonly transmitted through contaminated food such as unpasteurized dairy products, processed meats, and raw vegetables. Although many individuals may carry the organism asymptomatically in their gastrointestinal tract, it can cause serious invasive disease, particularly in vulnerable populations. The infection may present in several clinical forms, including febrile gastroenteritis, central nervous system involvement, bacteremia, infection during pregnancy, neonatal infection, and focal infections in various organs.
The disease occurs worldwide and may appear as sporadic cases or outbreaks, often linked to food contamination. While listeriosis can affect healthy individuals, those at higher risk include neonates, elderly individuals, pregnant women, and immunocompromised patients. Pregnancy-associated listeriosis is particularly significant, accounting for a substantial proportion of cases and often presenting with mild, flu-like symptoms in the mother but potentially leading to severe fetal complications such as miscarriage, stillbirth, or neonatal infection.
The pathophysiology varies depending on the clinical syndrome. In healthy individuals, ingestion of the organism may lead to a self-limited febrile gastroenteritis. However, in high-risk groups, the bacteria can invade the bloodstream and spread to the central nervous system, causing meningitis or meningoencephalitis. These CNS infections may present subtly, often with mild fever and altered mental status rather than classic meningeal signs. In neonates, infection may present early with sepsis or pneumonia, or later with meningitis, and in severe cases can manifest as granulomatosis infantiseptica, a disseminated and life-threatening condition.
Diagnosis is based on clinical suspicion supported by laboratory findings. Blood cultures and cerebrospinal fluid analysis are key in detecting invasive disease. Imaging, particularly brain MRI, is useful in patients with neurological symptoms. Stool cultures are generally not helpful, and there are no specific clinical signs that definitively establish the diagnosis, making awareness of risk factors and presentations essential.
Treatment depends on the severity and form of the disease. Mild gastroenteritis in immunocompetent individuals may not require antibiotics, whereas invasive disease requires prompt antimicrobial therapy. First-line treatment typically includes ampicillin or penicillin G, often combined with gentamicin in severe cases. Trimethoprim-sulfamethoxazole is an alternative, particularly in patients with allergies. Treatment duration varies from a few days in mild cases to several weeks in CNS or systemic infections. Hospitalization is required for patients with invasive disease.
The prognosis of listeriosis varies widely. While mild forms have an excellent outcome, invasive infections, especially meningitis and endocarditis, are associated with high mortality rates. Complications may include neurological deficits, seizures, and systemic spread of infection. In pregnancy, adverse fetal outcomes are a major concern. Prevention focuses on proper food handling, avoiding high-risk foods such as unpasteurized dairy products, and maintaining good hygiene practices, particularly in high-risk populations.
Listeriosis is an infection caused by the gram-positive bacterium Listeria monocytogenes, which is commonly transmitted through contaminated food such as unpasteurized dairy products, processed meats, and raw vegetables. Although many individuals may carry the organism asymptomatically in their gastrointestinal tract, it can cause serious invasive disease, particularly in vulnerable populations. The infection may present in several clinical forms, including febrile gastroenteritis, central nervous system involvement, bacteremia, infection during pregnancy, neonatal infection, and focal infections in various organs.
The disease occurs worldwide and may appear as sporadic cases or outbreaks, often linked to food contamination. While listeriosis can affect healthy individuals, those at higher risk include neonates, elderly individuals, pregnant women, and immunocompromised patients. Pregnancy-associated listeriosis is particularly significant, accounting for a substantial proportion of cases and often presenting with mild, flu-like symptoms in the mother but potentially leading to severe fetal complications such as miscarriage, stillbirth, or neonatal infection.
The pathophysiology varies depending on the clinical syndrome. In healthy individuals, ingestion of the organism may lead to a self-limited febrile gastroenteritis. However, in high-risk groups, the bacteria can invade the bloodstream and spread to the central nervous system, causing meningitis or meningoencephalitis. These CNS infections may present subtly, often with mild fever and altered mental status rather than classic meningeal signs. In neonates, infection may present early with sepsis or pneumonia, or later with meningitis, and in severe cases can manifest as granulomatosis infantiseptica, a disseminated and life-threatening condition.
Diagnosis is based on clinical suspicion supported by laboratory findings. Blood cultures and cerebrospinal fluid analysis are key in detecting invasive disease. Imaging, particularly brain MRI, is useful in patients with neurological symptoms. Stool cultures are generally not helpful, and there are no specific clinical signs that definitively establish the diagnosis, making awareness of risk factors and presentations essential.
Treatment depends on the severity and form of the disease. Mild gastroenteritis in immunocompetent individuals may not require antibiotics, whereas invasive disease requires prompt antimicrobial therapy. First-line treatment typically includes ampicillin or penicillin G, often combined with gentamicin in severe cases. Trimethoprim-sulfamethoxazole is an alternative, particularly in patients with allergies. Treatment duration varies from a few days in mild cases to several weeks in CNS or systemic infections. Hospitalization is required for patients with invasive disease.
The prognosis of listeriosis varies widely. While mild forms have an excellent outcome, invasive infections, especially meningitis and endocarditis, are associated with high mortality rates. Complications may include neurological deficits, seizures, and systemic spread of infection. In pregnancy, adverse fetal outcomes are a major concern. Prevention focuses on proper food handling, avoiding high-risk foods such as unpasteurized dairy products, and maintaining good hygiene practices, particularly in high-risk populations.
- Published on
Infectious Disease and Microbiology - Lice
Lice infestation, also known as pediculosis, is caused by ectoparasitic insects of the order Phthiraptera that live on human hair and skin. It is not an infection but an infestation, involving three main types depending on location: head lice, body lice, and pubic lice. The causative organisms include Pediculus humanus capitis, Pediculus humanus corporis, and Phthirus pubis. These parasites feed on human blood and complete their life cycle entirely on the host, with eggs (nits) hatching into nymphs that mature into adults within a few weeks.
Head lice infestation is particularly common among school-aged children and spreads mainly through close personal contact. It is not strongly linked to poor hygiene but is associated with crowding and household size. Body lice are more commonly seen in individuals with poor hygiene, especially among homeless populations or in crowded environments such as refugee camps. Pubic lice are typically transmitted through sexual contact and are therefore considered a sexually transmitted condition, often associated with other sexually transmitted infections.
The main symptom of lice infestation is pruritus, which results from a hypersensitivity reaction to lice saliva. The itching varies depending on the site of infestation and may lead to excoriations and secondary bacterial infections. Physical examination is diagnostic, revealing live lice or nits attached to hair shafts or clothing fibers. In head lice, careful combing of wet hair can improve detection. Pubic lice may also affect other coarse hair regions, including eyelashes, and characteristic bluish-gray skin lesions known as maculae ceruleae may appear.
Diagnosis is clinical and does not require laboratory testing. However, in cases of pubic lice, evaluation for coexisting sexually transmitted diseases is recommended. Body lice infestations may be associated with transmission of certain pathogens, including Bartonella quintana and, less commonly, Rickettsia prowazekii, making recognition important in vulnerable populations.
Treatment primarily involves topical insecticides, with permethrin 1% being the first-line therapy for most infestations. Reapplication after 7 to 10 days is often necessary to eradicate newly hatched lice. Alternative treatments include malathion, lindane (with caution due to potential toxicity), and oral ivermectin in selected cases. Proper application technique is essential for treatment success, as resistance or improper use may lead to persistence of infestation.
Supportive measures include washing clothing, bedding, and personal items in hot water, particularly for body lice. For pubic lice affecting the eyelashes, petroleum jelly may be used. Mechanical removal of lice and nits can be helpful but is generally less effective when used alone. The prognosis is excellent with appropriate treatment, although reinfestation can occur if contacts are not treated simultaneously.
Complications are usually mild and include secondary bacterial skin infections due to scratching. In certain cases, particularly with body lice, there is a risk of transmission of systemic infections. Psychological distress, especially among children and caregivers, is also a notable consequence of infestation.
Lice infestation, also known as pediculosis, is caused by ectoparasitic insects of the order Phthiraptera that live on human hair and skin. It is not an infection but an infestation, involving three main types depending on location: head lice, body lice, and pubic lice. The causative organisms include Pediculus humanus capitis, Pediculus humanus corporis, and Phthirus pubis. These parasites feed on human blood and complete their life cycle entirely on the host, with eggs (nits) hatching into nymphs that mature into adults within a few weeks.
Head lice infestation is particularly common among school-aged children and spreads mainly through close personal contact. It is not strongly linked to poor hygiene but is associated with crowding and household size. Body lice are more commonly seen in individuals with poor hygiene, especially among homeless populations or in crowded environments such as refugee camps. Pubic lice are typically transmitted through sexual contact and are therefore considered a sexually transmitted condition, often associated with other sexually transmitted infections.
The main symptom of lice infestation is pruritus, which results from a hypersensitivity reaction to lice saliva. The itching varies depending on the site of infestation and may lead to excoriations and secondary bacterial infections. Physical examination is diagnostic, revealing live lice or nits attached to hair shafts or clothing fibers. In head lice, careful combing of wet hair can improve detection. Pubic lice may also affect other coarse hair regions, including eyelashes, and characteristic bluish-gray skin lesions known as maculae ceruleae may appear.
Diagnosis is clinical and does not require laboratory testing. However, in cases of pubic lice, evaluation for coexisting sexually transmitted diseases is recommended. Body lice infestations may be associated with transmission of certain pathogens, including Bartonella quintana and, less commonly, Rickettsia prowazekii, making recognition important in vulnerable populations.
Treatment primarily involves topical insecticides, with permethrin 1% being the first-line therapy for most infestations. Reapplication after 7 to 10 days is often necessary to eradicate newly hatched lice. Alternative treatments include malathion, lindane (with caution due to potential toxicity), and oral ivermectin in selected cases. Proper application technique is essential for treatment success, as resistance or improper use may lead to persistence of infestation.
Supportive measures include washing clothing, bedding, and personal items in hot water, particularly for body lice. For pubic lice affecting the eyelashes, petroleum jelly may be used. Mechanical removal of lice and nits can be helpful but is generally less effective when used alone. The prognosis is excellent with appropriate treatment, although reinfestation can occur if contacts are not treated simultaneously.
Complications are usually mild and include secondary bacterial skin infections due to scratching. In certain cases, particularly with body lice, there is a risk of transmission of systemic infections. Psychological distress, especially among children and caregivers, is also a notable consequence of infestation.
- Published on
Infectious Disease and Microbiology - Leptospirosis
Leptospirosis is a zoonotic infectious disease caused by the spirochete Leptospira interrogans. It is transmitted primarily through contact with water, soil, or vegetation contaminated with the urine of infected animals, particularly rodents, which serve as the main reservoir. The organism enters the body through abraded skin or mucous membranes and disseminates hematogenously, affecting multiple organs. The disease is globally distributed and often underdiagnosed, with many infections remaining asymptomatic or presenting as nonspecific febrile illness.
Epidemiologically, leptospirosis is more common in tropical and subtropical regions, though it occurs worldwide. It is associated with occupational and recreational exposure, affecting farmers, sewer workers, veterinarians, and individuals exposed to contaminated water such as swimmers or campers. Outbreaks are often linked to flooding and poor sanitation, especially in urban slum settings. The incubation period typically ranges from 1 to 2 weeks but can vary from a few days to several weeks.
Clinically, leptospirosis presents with a wide spectrum of manifestations. The anicteric form is more common and characterized by fever, chills, severe myalgia (especially in the calf muscles), headache, and conjunctival suffusion. The disease may be biphasic, with an initial septicemic phase followed by an immune phase involving meningitis or other organ systems. In severe cases, patients develop icteric leptospirosis, also known as Weil’s syndrome, which is marked by jaundice, renal failure, and hemorrhagic complications. Neurological, respiratory, and gastrointestinal symptoms may also occur, reflecting multisystem involvement.
Diagnosis relies on a combination of clinical suspicion and laboratory testing. Direct visualization of leptospires may be possible using dark-field microscopy in blood, urine, or cerebrospinal fluid early in the disease. Serologic testing, particularly the microscopic agglutination test, is the reference standard, while detection of IgM antibodies and PCR-based methods provide additional diagnostic support. Laboratory abnormalities often include thrombocytopenia, elevated liver enzymes, renal dysfunction, and increased creatine phosphokinase levels. Imaging studies such as chest radiography may be necessary in patients with pulmonary involvement.
Treatment depends on disease severity. Mild cases can be managed with oral antibiotics such as doxycycline or azithromycin, whereas severe disease requires intravenous therapy, most commonly with penicillin G or ceftriaxone for approximately 7 days. Supportive care is crucial, especially in cases complicated by renal failure or respiratory distress, and specialist consultation may be necessary. Early initiation of antibiotics significantly improves outcomes.
The prognosis is generally favorable in mild disease, but severe leptospirosis carries a significant mortality risk, particularly when associated with hepatic and renal failure. Complications include hepatorenal syndrome, acute respiratory distress syndrome, myocarditis, and severe hemorrhage. Preventive measures focus on reducing exposure, including rodent control, use of protective clothing, and in selected high-risk individuals, chemoprophylaxis with doxycycline.
Leptospirosis is a zoonotic infectious disease caused by the spirochete Leptospira interrogans. It is transmitted primarily through contact with water, soil, or vegetation contaminated with the urine of infected animals, particularly rodents, which serve as the main reservoir. The organism enters the body through abraded skin or mucous membranes and disseminates hematogenously, affecting multiple organs. The disease is globally distributed and often underdiagnosed, with many infections remaining asymptomatic or presenting as nonspecific febrile illness.
Epidemiologically, leptospirosis is more common in tropical and subtropical regions, though it occurs worldwide. It is associated with occupational and recreational exposure, affecting farmers, sewer workers, veterinarians, and individuals exposed to contaminated water such as swimmers or campers. Outbreaks are often linked to flooding and poor sanitation, especially in urban slum settings. The incubation period typically ranges from 1 to 2 weeks but can vary from a few days to several weeks.
Clinically, leptospirosis presents with a wide spectrum of manifestations. The anicteric form is more common and characterized by fever, chills, severe myalgia (especially in the calf muscles), headache, and conjunctival suffusion. The disease may be biphasic, with an initial septicemic phase followed by an immune phase involving meningitis or other organ systems. In severe cases, patients develop icteric leptospirosis, also known as Weil’s syndrome, which is marked by jaundice, renal failure, and hemorrhagic complications. Neurological, respiratory, and gastrointestinal symptoms may also occur, reflecting multisystem involvement.
Diagnosis relies on a combination of clinical suspicion and laboratory testing. Direct visualization of leptospires may be possible using dark-field microscopy in blood, urine, or cerebrospinal fluid early in the disease. Serologic testing, particularly the microscopic agglutination test, is the reference standard, while detection of IgM antibodies and PCR-based methods provide additional diagnostic support. Laboratory abnormalities often include thrombocytopenia, elevated liver enzymes, renal dysfunction, and increased creatine phosphokinase levels. Imaging studies such as chest radiography may be necessary in patients with pulmonary involvement.
Treatment depends on disease severity. Mild cases can be managed with oral antibiotics such as doxycycline or azithromycin, whereas severe disease requires intravenous therapy, most commonly with penicillin G or ceftriaxone for approximately 7 days. Supportive care is crucial, especially in cases complicated by renal failure or respiratory distress, and specialist consultation may be necessary. Early initiation of antibiotics significantly improves outcomes.
The prognosis is generally favorable in mild disease, but severe leptospirosis carries a significant mortality risk, particularly when associated with hepatic and renal failure. Complications include hepatorenal syndrome, acute respiratory distress syndrome, myocarditis, and severe hemorrhage. Preventive measures focus on reducing exposure, including rodent control, use of protective clothing, and in selected high-risk individuals, chemoprophylaxis with doxycycline.
- Published on
Infectious Disease and Microbiology - Keratitis
Keratitis refers to inflammation of the cornea that may be caused by infectious or noninfectious processes. Infectious keratitis can result from bacteria, viruses, fungi, or parasites, and bacterial keratitis is often referred to as a corneal ulcer. A major global cause of keratitis-related blindness is trachoma due to Chlamydia trachomatis, which leads to chronic inflammation, eyelid deformities, and corneal scarring.
The condition occurs worldwide, with bacterial keratitis being more common among contact lens users. Risk factors include disruption of the corneal epithelial surface, poor contact lens hygiene, overnight lens use, and ocular trauma. In critically ill patients, factors such as inability to close the eyes, reduced blinking, and dry eye contribute to risk. Fungal keratitis is more common in warm climates and often follows trauma with plant material, while trachoma is associated with poor hygiene and limited access to water.
The pathophysiology involves a break in the corneal epithelium that allows microorganisms to enter and proliferate in the corneal stroma. Some organisms possess adhesins that facilitate attachment to corneal cells. Viral causes such as Herpes simplex virus type 1 can remain latent in the trigeminal ganglion and reactivate, leading to recurrent disease. Similarly, Varicella zoster virus may reactivate later in life, causing herpes zoster ophthalmicus when the trigeminal nerve is involved.
A wide range of organisms can cause keratitis. Bacterial causes include Pseudomonas, Staphylococcus, and Streptococcus species, with Pseudomonas being particularly aggressive in contact lens users. Viral causes include HSV and VZV, with HSV producing characteristic dendritic lesions. Fungal organisms such as Aspergillus and Fusarium cause more indolent infections, while parasites such as Acanthamoeba can produce severe pain and characteristic ring-shaped infiltrates.
Patients typically present with eye pain, redness, foreign body sensation, photophobia, tearing, discharge, and reduced vision. Severe pain that is disproportionate to clinical findings is suggestive of Acanthamoeba infection. Viral keratitis may lead to reduced corneal sensation. Herpes zoster ophthalmicus may be preceded by a flu-like illness and is associated with a dermatomal rash, especially involving the tip of the nose.
On examination, slit-lamp findings include epithelial defects, stromal infiltrates, and anterior chamber inflammation. Fluorescein staining highlights epithelial defects. Severe cases may show hypopyon. Bacterial ulcers may appear as rapidly spreading infiltrates, while fungal keratitis often shows feathery borders and satellite lesions. HSV infection classically produces branching dendritic ulcers, while late Acanthamoeba infection may show a ring infiltrate.
Diagnosis is primarily clinical but supported by laboratory studies. Corneal scrapings are obtained for staining and culture to identify the causative organism. Special stains and media are used depending on suspected pathogens. PCR and viral testing may be used for herpetic infections, while confocal microscopy can help identify Acanthamoeba cysts.
Management depends on the underlying cause but must be initiated promptly. Suspected bacterial keratitis requires immediate empiric broad-spectrum topical antibiotics, often administered hourly. Severe cases may require fortified antibiotic drops. Fungal keratitis is treated with topical antifungals such as natamycin or amphotericin B, often for prolonged periods. Acanthamoeba infections require specific agents such as polyhexamethylene biguanide and are difficult to eradicate. Viral keratitis due to HSV is treated with topical antivirals, while deeper stromal disease may require cautious use of topical steroids along with antiviral coverage. Herpes zoster ophthalmicus is treated with systemic antiviral therapy.
Prognosis depends on the severity, location, and timeliness of treatment. Early treatment generally leads to good outcomes, but delayed therapy can result in significant visual impairment. Complications include corneal scarring, thinning, perforation, and secondary infections such as endophthalmitis. Chronic or recurrent infections, particularly with HSV, may lead to permanent visual loss and require surgical intervention such as corneal transplantation.
- Published on
Infectious Disease and Microbiology
Kawasaki syndrome (Kawasaki disease, KD)
Kawasaki syndrome is an acute, self-limited systemic vasculitis that primarily affects young children, especially those under 5 years of age. It is also known as mucocutaneous lymph node syndrome. Although the disease often resolves on its own, it is clinically significant because it can lead to serious cardiovascular complications, particularly coronary artery aneurysms.
The disease occurs worldwide but is most common in Japan, with most cases seen in children younger than 5 years. It can occur throughout the year, with peaks during winter and spring. Risk factors include recent respiratory infections and environmental exposures such as dust and mites. Genetic susceptibility also plays a role, with involvement of pathways such as caspase-3 and TGF-beta.
Kawasaki syndrome involves inflammation of medium and small blood vessels. In the early stage, there is endothelial swelling and inflammation, which later progresses to widespread systemic inflammation affecting multiple organs, especially the heart. Although the exact cause remains unknown, the condition is believed to be triggered by an infectious agent, possibly through a superantigen-mediated immune response.
Clinically, the diagnosis is based on the presence of fever lasting at least five days along with characteristic features. These include a polymorphous rash, bilateral non-purulent conjunctivitis, oral changes such as cracked lips and strawberry tongue, swelling and redness of the hands and feet followed by peeling, and cervical lymphadenopathy. Incomplete forms of the disease may occur and should still be treated if suspected. Other symptoms may include irritability, joint pain, myocarditis, pericarditis, aseptic meningitis, and gastrointestinal symptoms.
Laboratory findings commonly show anemia, leukocytosis, and thrombocytosis, particularly in later stages. Inflammatory markers such as ESR and CRP are elevated, and hypoalbuminemia and elevated liver enzymes may also be present. Echocardiography is essential to evaluate for coronary artery involvement, while ECG may reveal arrhythmias or other cardiac changes.
Management should be initiated promptly to reduce the risk of complications. The mainstay of treatment is intravenous immunoglobulin (IVIG), given as a single high-dose infusion, with a repeat dose if fever persists. Aspirin is also used, initially at high doses for its anti-inflammatory effect and later at lower doses for its antiplatelet properties. In resistant cases, corticosteroids or agents such as infliximab may be used. Patients with coronary complications may require anticoagulation and specialist cardiac care.
The prognosis is generally good when treated early. Without treatment, a significant proportion of patients develop coronary artery aneurysms, but this risk is markedly reduced with timely therapy. Long-term follow-up with echocardiography is important, especially in those with cardiac involvement.
Complications are mainly cardiovascular and include coronary artery aneurysms, myocardial infarction, myocarditis, and pericarditis, with myocardial infarction being the most common cause of death. Non-cardiac complications may include hearing loss, arthritis, pneumonitis, and macrophage activation syndrome.
